Cite
MLA Citation
T A Chan et al.. “Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.” Annals of oncology, vol. 30, 2019, pp. 44–56. http://access.bl.uk/ark:/81055/vdc_100094061057.0x000035
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
T A Chan et al.. “Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.” Annals of oncology, vol. 30, 2019, pp. 44–56. http://access.bl.uk/ark:/81055/vdc_100094061057.0x000035